<!--
title: Serum sickness-like reaction following an administration of the first dose of inactivated COVID19 vaccine
description: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582082/
published: true
date: 2022-01-13T13:35:31.701Z
tags: #vaccine, #risk, #sideeffects, #covid19, #side, #effects, #effect, #administration, #sickness, #inactivated, #sslr, #serum, #reaction
editor: ckeditor
dateCreated: 2022-01-13T13:35:29.354Z
-->

<p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582082/#">JAAD Case Rep.</a> 2022 Jan; 19: 21–24.</p>
<p>Published online 2021 Nov 11. doi:&nbsp;<a href="https://dx.doi.org/10.1016%2Fj.jdcr.2021.11.004">10.1016/j.jdcr.2021.11.004</a></p>
<p style="text-align:right;">PMCID: PMC8582082</p>
<p style="text-align:right;">PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/34786444">34786444</a></p>
<p>&nbsp;</p>
<h1>Serum sickness-like reaction following an administration of the first dose of inactivated COVID19 vaccine</h1>
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Chaijaras%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34786444">Sasipim Chaijaras</a>, MD,<sup>a</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Seree-aphinan%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34786444">Chutima Seree-aphinan</a>, MD,<sup>a</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Rutnin%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34786444">Suthinee Rutnin</a>, MD,<sup>a</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Ngamjanyaporn%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34786444">Pintip Ngamjanyaporn</a>, MD,<sup>b</sup> and <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Rattanakaemakorn%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34786444">Ploysyne Rattanakaemakorn</a>, MD<sup>a,∗</sup></p>
<p style="text-align:right;">&nbsp;</p>
<h2>Introduction</h2>
<p>Numerous vaccine-related adverse reactions have emerge amidst an emergency rollout of COVID-19 vaccines. The nature and incidence of these reactions vary according to the type of vaccine. An inactivated COVID19 vaccine (CoronaVac) is widely distributed in Thailand and several other countries. It has been considered relatively safe, with the most commonly encountered side effects being injection site reactions, fever, fatigue, diarrhea, and muscle pain.<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582082/#bib1">1</a> Regarding cutaneous side effects, discoloration at the injection site and pruritus have been reported from vaccine trials.<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582082/#bib1">1</a> Herein, we present a case of a severe adverse reaction to the inactivated COVID19 vaccine. The patient developed serum sickness-like reactions (SSLRs) 4&nbsp;days after receiving the first dose of the vaccine, which required a prolonged course of systemic corticosteroid and precluded the patient from receiving further doses of the vaccine. This condition occurs rarely in association with vaccination; previous cases were found only in case reports and small observational studies.<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582082/#bib2">2</a>, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582082/#bib3">3</a>, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582082/#bib4">4</a></p>
<p>&nbsp;</p>
<p>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582082/</p>
